JP2587705B2 - 4-desoxy-4-epipodophyllotoxin derivatives - Google Patents

4-desoxy-4-epipodophyllotoxin derivatives

Info

Publication number
JP2587705B2
JP2587705B2 JP26785589A JP26785589A JP2587705B2 JP 2587705 B2 JP2587705 B2 JP 2587705B2 JP 26785589 A JP26785589 A JP 26785589A JP 26785589 A JP26785589 A JP 26785589A JP 2587705 B2 JP2587705 B2 JP 2587705B2
Authority
JP
Japan
Prior art keywords
group
desoxy
compound
epipodophyllotoxin
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP26785589A
Other languages
Japanese (ja)
Other versions
JPH03127792A (en
Inventor
秀夫 山口
忠史 寺田
誠 野村
勝彦 藤本
純一 山下
節夫 武田
コンスタンティ ヴィエジバ
尚 小武内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP26785589A priority Critical patent/JP2587705B2/en
Publication of JPH03127792A publication Critical patent/JPH03127792A/en
Application granted granted Critical
Publication of JP2587705B2 publication Critical patent/JP2587705B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】 産業上の利用分野 本発明は抗腫瘍活性を有し抗腫瘍剤として有用な、新
規4−デソキシ−4−エピポドフィロトキシン誘導体に
関する。
Description: TECHNICAL FIELD The present invention relates to a novel 4-desoxy-4-epipodophyllotoxin derivative having antitumor activity and useful as an antitumor agent.

従来の技術 抗腫瘍作用を有するポドフィロトキシンの誘導体は古
くから知られており、その代表的な化合物としてはエト
ポシド、テニポシド等が挙げられる。しかし副作用等、
臨床上の問題があり、十分に満足できる化合物はまだ得
られていない。
2. Description of the Related Art Podophyllotoxin derivatives having antitumor activity have been known for a long time, and typical compounds thereof include etoposide, teniposide and the like. But side effects,
Due to clinical problems, fully satisfactory compounds have not yet been obtained.

発明が解決しようとする問題点 本発明の目的は優れた抗腫瘍活性を有し、腫瘍の治療
薬として有用な化合物を提供することにある。
Problems to be Solved by the Invention An object of the present invention is to provide a compound having excellent antitumor activity and useful as a therapeutic agent for tumors.

本発明者らはポドフィロトキシン誘導体を鋭意研究し
た結果、極めて強い抗腫瘍活性を有する化合物を見出し
本発明を完成させた。
The present inventors have conducted intensive studies on podophyllotoxin derivatives, and as a result, found a compound having extremely strong antitumor activity and completed the present invention.

問題を解決するための手段 本発明は下記一般式(I)で表わされる4−デソキシ
−4−エピポドフィロトキシン誘導体に関する。
Means for Solving the Problems The present invention relates to a 4-desoxy-4-epipodophyllotoxin derivative represented by the following general formula (I).

[式中R1は水素原子又はメチル基を、Rは低級アルケニ
ル基又は置換基として水酸基若しくはアセトキシ基を有
してもよい低級アルキル基を示す。] 一般式(I)で表わされる本発明化合物は、優れた抗
腫瘍活性を有しており、種々の腫瘍の治療に有効であ
る。
[In the formula, R 1 represents a hydrogen atom or a methyl group, and R represents a lower alkenyl group or a lower alkyl group which may have a hydroxyl group or an acetoxy group as a substituent. The compound of the present invention represented by the general formula (I) has excellent antitumor activity and is effective for treating various tumors.

上記一般式(I)においてRで示される低級アルケニ
ル基としては、ビニル基、1−プロペニル基、イソプロ
ペニル基、アリル基、2−ブテニル基、2−メチル−2
−ブテニル基、3−ペンテニル基、4−ヘキセニル基等
の炭素数2〜6の直鎖状又は分枝状のアルケニル基を例
示することができる。低級アルキル基としては、メチル
基、エチル基、プロピル基、イソプロピル基、n−ブチ
ル基、イソブチル基、sec−ブチル基、tert−ブチル
基、ペンチル基、イソペンチル基、ヘキシル基等の炭素
数1〜6の直鎖状または分枝状のアルキル基を例示する
ことができる。水酸基を有する低級アルキル基として
は、ヒドロキシメチル基、2−ヒドロキシエチル基、2
−ヒドロキシプロピル基、3−ヒドロキシプロピル基、
2,3−ジヒドロキシプロピル基、2,3−ジヒドロキシブチ
ル基、2,3−ジヒドロキシペンチル基、2,3−ジヒドロキ
シヘキシル基等の水酸基を1個又は2個含む炭素数1〜
6の直鎖状または分枝状のアルキル基を、アセトキシ基
を有する低級アルキル基としては、アセトキシメチル
基、2−アセトキシエチル基、2−アセトキシプロピル
基、3−アセトキシプロピル基、2,3−ジアセトキシプ
ロピル基、2,3−ジアセトキシブチル基、2,3−ジアセト
キシペンチル基、2,3−ジアセトキシヘキシル基等のア
セトキシ基を1又は2個含む炭素数1〜6の直鎖状又は
分枝状のアルキル基を例示することができる。
Examples of the lower alkenyl group represented by R in the above general formula (I) include a vinyl group, a 1-propenyl group, an isopropenyl group, an allyl group, a 2-butenyl group and a 2-methyl-2.
Examples thereof include linear or branched alkenyl groups having 2 to 6 carbon atoms, such as -butenyl, 3-pentenyl, and 4-hexenyl groups. Examples of the lower alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a pentyl group, an isopentyl group, and a hexyl group. And 6 linear or branched alkyl groups. Examples of the lower alkyl group having a hydroxyl group include a hydroxymethyl group, a 2-hydroxyethyl group,
-Hydroxypropyl group, 3-hydroxypropyl group,
1,3-dihydroxypropyl, 2,3-dihydroxybutyl, 2,3-dihydroxypentyl, 2,3-dihydroxyhexyl, etc.
6 is a lower alkyl group having an acetoxy group, wherein the lower alkyl group having an acetoxy group includes an acetoxymethyl group, a 2-acetoxyethyl group, a 2-acetoxypropyl group, a 3-acetoxypropyl group, C1-C6 straight chain containing one or two acetoxy groups such as diacetoxypropyl, 2,3-diacetoxybutyl, 2,3-diacetoxypentyl, and 2,3-diacetoxyhexyl Alternatively, a branched alkyl group can be exemplified.

本発明の4−デソキシ−4−エピポドフィロトキシン
誘導体は、例えば下記反応工程式1に従い製造すること
ができる。
The 4-desoxy-4-epipodophyllotoxin derivative of the present invention can be produced, for example, according to the following reaction scheme 1.

[式中R1は水素原子又はメチル基を、R2は低級アルケニ
ル基を、R3は低級アルキル基を、R4は水酸基を有する低
級アルキル基を、R5はアセトキシ基を有する低級アルキ
ル基を示す。] 以下に上記反応式の各工程につき説明する。
Wherein R 1 is a hydrogen atom or a methyl group, R 2 is a lower alkenyl group, R 3 is a lower alkyl group, R 4 is a lower alkyl group having a hydroxyl group, and R 5 is a lower alkyl group having an acetoxy group. Is shown. Hereinafter, each step of the above reaction formula will be described.

<A工程> 一般式(II)で表わされる4−エピポドフィロトキシ
ンと一般式(III)で表わされる低級アルケニルシラン
を適当な溶媒中でルイス酸存在下に反応させることによ
り、一般式(I)中Rが低級アルケニル基である目的の
化合物(I a)を得る。溶媒としては反応に関与しない
ものであれば特に制限はなく、例えばジクロロメタン、
クロロホルム、1,2−ジクロロエタン、テトラヒドロフ
ラン、ジオキサン等の非プロトン性溶媒が使用できる。
ルイス酸としては、例えば、四塩化チタン、トリメチル
シリルトリフルオロメタンスルホネート、臭化亜鉛、三
フッ化ホウ素エチルエーテル等が使用できる。反応の割
合は、一般式(III)の化合物を一般式(II)の化合物
の1〜5倍モル量、ルイス酸を一般式(II)の化合物の
0.5〜3倍モル量用いるのが好ましい。又、反応温度は
−100〜100℃、好ましくは−20〜20℃で行われる。
<Step A> By reacting 4-epipodophyllotoxin represented by the general formula (II) with lower alkenylsilane represented by the general formula (III) in a suitable solvent in the presence of a Lewis acid, I) The target compound (Ia) in which R is a lower alkenyl group is obtained. The solvent is not particularly limited as long as it does not participate in the reaction, for example, dichloromethane,
Aprotic solvents such as chloroform, 1,2-dichloroethane, tetrahydrofuran, dioxane and the like can be used.
As the Lewis acid, for example, titanium tetrachloride, trimethylsilyltrifluoromethanesulfonate, zinc bromide, boron trifluoride ethyl ether and the like can be used. The reaction ratio is such that the compound of the general formula (III) is 1 to 5 times the molar amount of the compound of the general formula (II), and the Lewis acid is the compound of the general formula (II).
It is preferable to use 0.5 to 3 times the molar amount. The reaction is carried out at a temperature of -100 to 100C, preferably -20 to 20C.

<B工程> A工程で得られた一般式(I a)で表わされる誘導体
を不活性溶媒中、触媒の存在下に接触還元することによ
り、一般式(I)中Rが低級アルキル基である目的の化
合物(I b)を得る。溶媒としては例えば酢酸エチル、
メタノール、テトラヒドロフラン等を単独で又は混合し
て使用できる。触媒としては、例えばパラジウム黒、白
金等が使用できる。水素圧は常圧〜3気圧、好ましくは
常圧〜2気圧である。反応温度は0〜40℃、好ましくは
室温である。
<Step B> The derivative represented by the general formula (Ia) obtained in the step A is catalytically reduced in an inert solvent in the presence of a catalyst, whereby R in the general formula (I) is a lower alkyl group. The desired compound (Ib) is obtained. As the solvent, for example, ethyl acetate,
Methanol, tetrahydrofuran or the like can be used alone or in combination. As the catalyst, for example, palladium black, platinum or the like can be used. The hydrogen pressure is from normal pressure to 3 atm, preferably from normal pressure to 2 atm. The reaction temperature is 0 to 40 ° C, preferably room temperature.

<C工程> A工程で得られた一般式(I )で表わされる誘導体を
不活性溶媒中で酸化することにより、一般式(I)中R
が水酸基を有する低級アルキル基である目的の化合物
(I c)を得る。溶媒としては例えば四塩化炭素、アセ
トニトリル、酢酸、水、ピリジン等を単独で又は混合し
て使用できる。酸化剤としては、例えば酸化ルテニウ
ム、過ヨウ素酸ナトリウム、四酸化オスミウム等が使用
できる。反応の割合は一般式(I a)の化合物に対し酸
化剤を0.1〜2倍モル量用いるのが好ましい。反応温度
は−10〜80℃、好ましくは0〜20℃である。
<Step C> The derivative represented by the general formula (I) obtained in the step A is oxidized in an inert solvent to give R in the general formula (I).
Is a lower alkyl group having a hydroxyl group to obtain the desired compound (Ic). As the solvent, for example, carbon tetrachloride, acetonitrile, acetic acid, water, pyridine and the like can be used alone or as a mixture. As the oxidizing agent, for example, ruthenium oxide, sodium periodate, osmium tetroxide and the like can be used. The reaction rate is preferably such that the oxidizing agent is used in an amount of 0.1 to 2 moles per mole of the compound of the formula (Ia). The reaction temperature is -10 to 80C, preferably 0 to 20C.

<D工程> C工程で得られた一般式(I c)で表わされる誘導体
を不活性溶媒中、塩基の存在下にアセチル化することに
より、一般式(I)中Rがアセトキシ基を有する低級ア
ルキル基である目的の化合物(I d)を得る。溶媒とし
ては例えばベンゼン、テトラヒドロフラン、ジクロロメ
タン等を使用できる。塩基としては、例えばピリジン、
ジメチルアミノピリジン、イミダゾール等が使用でき
る。アセチル化剤としては塩化アセチル、無水酢酸等が
使用できる。反応の割合は一般式(I c)の化合物に対
しアセチル化剤を1〜3倍モル量、塩基を0.1〜3倍モ
ル量用いるのが好ましい。反応温度は0〜60℃、好まし
くは0〜20℃である。
<Step D> The derivative represented by the general formula (Ic) obtained in the step C is acetylated in an inert solvent in the presence of a base, whereby R in the general formula (I) has an acetoxy group. The target compound (Id) which is an alkyl group is obtained. As the solvent, for example, benzene, tetrahydrofuran, dichloromethane and the like can be used. As the base, for example, pyridine,
Dimethylaminopyridine, imidazole and the like can be used. As the acetylating agent, acetyl chloride, acetic anhydride and the like can be used. The reaction rate is preferably 1 to 3 times the molar amount of the acetylating agent and 0.1 to 3 times the molar amount of the base, based on the compound of the formula (Ic). The reaction temperature is 0-60 ° C, preferably 0-20 ° C.

D工程で得られる化合物(I d)のうちR1が水素原子
である化合物は通常のエステル分解反応により加水分解
して、化合物(I c)のうちR1が水素原子の化合物を得
ることができる。
The compound obtained in step D compound wherein R 1 is hydrogen atom in (I d) is hydrolyzed by a conventional ester cleavage reaction, that R 1 of the compound (I c) to obtain a compound of hydrogen atoms it can.

上記反応工程式1中の化合物(I a)、(I b)、(I
c)及び(I d)のうちR1がメチル基の化合物は、通常の
脱メチル反応により、容易にR1が水素原子の本発明化合
物に変換できる。
Compounds (Ia), (Ib), (I
Of the compounds (c) and (Id), the compound in which R 1 is a methyl group can be easily converted to the compound of the present invention in which R 1 is a hydrogen atom by a usual demethylation reaction.

上記工程によって得られた化合物(I a)、(I b)、
(I c)及び(I d)は、濃縮、濾過、再結晶、各種クロ
マトグラフィー等の通常当分野で用いられる手段により
単離、精製される。
Compounds (Ia), (Ib),
(Ic) and (Id) are isolated and purified by means usually used in the art, such as concentration, filtration, recrystallization, and various types of chromatography.

実 施 例 本発明を更に詳しく説明するため、以下に実施例を挙
げる。
Examples Examples will be given below to explain the present invention in more detail.

実施例1 4−テソキシ−4−アリル−4−エピポドフィロトキシ
ン(化合物1)の合成 4−エピポドフィロトキシン500mg(1.2mmol)のジク
ロロメタン10ml溶液にトリメチルアリルシラン274mg
(2.4mmol)を加え、−10〜0℃に冷却した。この溶液
に三フッ化ホウ素エチルエーテル350μを加え4時間
撹拌した。反応後ピリジン350μを加え、酢酸エチル
で抽出した。有機層を乾燥後留去し、カラムクロマトグ
ラフィー(シリカ50g、展開溶媒;酢酸エチル:n−ヘキ
サン=1:2)で精製後、エーテル、n−ヘキサンにて結
晶化させ、濾集し、4−デソキシ−4−アリル−4−エ
ポピドフィロトキシン(化合物1)を450mg(収率81.1
%)得た。
Example 1 Synthesis of 4-tesoxy-4-allyl-4-epipodophyllotoxin (compound 1) 274 mg of trimethylallylsilane in a solution of 500 mg (1.2 mmol) of 4-epipodophyllotoxin in 10 ml of dichloromethane
(2.4 mmol) and cooled to -10 to 0 ° C. 350 μL of boron trifluoride ethyl ether was added to this solution and stirred for 4 hours. After the reaction, 350 μm of pyridine was added, and the mixture was extracted with ethyl acetate. The organic layer was dried and distilled off. The residue was purified by column chromatography (silica 50 g, developing solvent; ethyl acetate: n-hexane = 1: 2), crystallized from ether and n-hexane, and collected by filtration. -Desoxy-4-allyl-4-epopidophyllotoxin (compound 1) (450 mg, yield 81.1)
%)Obtained.

融点 93〜95℃ ▲[α]20 D▼=−85.20(C=0.500,CHCl31 H−NMR δppm(CDCl3) 6.73(1H,s,5位H),6.46(1H,s,8位H),6.29(2H,s,
2′,6′位H), 5.48−5.80(1H,m,−CH2CH=CH2),4.88−5.20(2H,m,
−CH=CH2),4.52(1H,d,J=3.6Hz,1位H), 3.78(3H,s,OCH3),3.74(6H,s,OCH3×2),2.80−3.40
(3H,m,2位、3位,4位H),2.24−2.60(2H,m,−CH2CH
=CH2) 実施例2 4−デソキシ−4−(1−プロピル)−4−エポピドフ
ィロトキシン(化合物2)の合成 実施例1で得た4−デソキシ−4−アリル−4−エピ
ポドフィロトキシン100mg(0.23mmol)の酢酸エチル:
メタノール(1:1)溶液10mlに5%パラジウム炭素10mg
を加え、水素気流中(1気合)で接触還元を行った。反
応後、5%パラジウム炭素を濾去し、濾液を減圧下濃縮
した。得られた残査をエーテル、n−ヘキサンにて結晶
化させ、濾集し、4−デソキシ−4−(1−プロピル)
−4−エピポドフィロトキシン(化合物2)を80mg(収
率79.7%)得た。
Melting point 93-95 ° C ▲ [α] 20 D ▼ = -85.20 (C = 0.500, CHCl 3 ) 1 H-NMR δ ppm (CDCl 3 ) 6.73 (1H, s, 5-position H), 6.46 (1H, s, 8) H), 6.29 (2H, s,
2 ', 6'-position H), 5.48-5.80 (1H, m, -CH 2 CH = CH 2), 4.88-5.20 (2H, m,
−CH = CH 2 ), 4.52 (1H, d, J = 3.6 Hz, first place H), 3.78 (3H, s, OCH 3 ), 3.74 (6H, s, OCH 3 × 2), 2.80-3.40
(3H, m, 2, 3, 4 H), 2.24-2.60 (2H, m , -CH 2 CH
= CH 2 ) Example 2 Synthesis of 4-desoxy-4- (1-propyl) -4-epopidophyllotoxin (Compound 2) 4-Desoxy-4-allyl-4-epipod obtained in Example 1 100 mg (0.23 mmol) of phyllotoxin ethyl acetate:
10% of 5% palladium on carbon in 10 ml of methanol (1: 1) solution
, And the catalytic reduction was carried out in a stream of hydrogen (one burst). After the reaction, 5% palladium carbon was removed by filtration, and the filtrate was concentrated under reduced pressure. The obtained residue was crystallized from ether and n-hexane, collected by filtration and 4-desoxy-4- (1-propyl).
80 mg (yield 79.7%) of -4-epipodophyllotoxin (compound 2) was obtained.

融点 114〜115℃ ▲[α]20 D▼=−74.28(C=0.520,CHCl31 H−NMR δppm(CDCl3) 6.69(1H,s,5位H),6.45(1H,s,8位H),6.28(2H,s,
2′,6′位H), 4.57(1H,m,1位H), 3.79(3H,s,OCH3),3.74(6H,s,OCH3×2),2.80−3.20
(3H,m,2位,3位,4位H),1.20−1.80(4H,m,−CH2CH2CH
3),0.98(3H,t,J=6.1Hz,−CH3) 実施例3 4−デソキシ−4′−デメチル−4−(1−プロピル)
−4−エピポドウィロトキシン(化合物3)の合成 実施例2で得た4−デソキシ−4−(1−プロピル)
−4−エピポドフィロトキシン80mg(0.18mmol)の1,2
−ジクロロエタン溶液5mlに、25%の臭化水素/酢酸1ml
を加え、室温で15時間撹拌した。反応後、溶液を留去
し、得られた残査をカラムクロマトグラフィー(シリ
カ;50g、展開溶媒;酢酸エチル:n−ヘキサン=1:4)で
精製後、エーテル、n−ヘキサンで結晶化させ、濾集
し、4−デソキシ−4′−デメチル−4−(1−プロピ
ル)−4−エピポドフィロトキシン(化合物3)を55mg
(収率71.7%)得た。
Melting point 114-115 ° C ▲ [α] 20 D ▼ = -74.28 (C = 0.520, CHCl 3 ) 1 H-NMR δ ppm (CDCl 3 ) 6.69 (1H, s, 5-position H), 6.45 (1H, s, 8) H), 6.28 (2H, s,
2 ', 6'-position H), 4.57 (1H, m, 1st H), 3.79 (3H, s, OCH 3 ), 3.74 (6H, s, OCH 3 × 2), 2.80-3.20
(3H, m, 2, 3, 4 H), 1.20-1.80 (4H, m , -CH 2 CH 2 CH
3), 0.98 (3H, t , J = 6.1Hz, -CH 3) Example 3 4-desoxy-4'-demethyl-4- (1-propyl)
Synthesis of 4-epipodwillotoxin (compound 3) 4-desoxy-4- (1-propyl) obtained in Example 2
-4- Epipodophyllotoxin 80 mg (0.18 mmol) 1,2
1 ml of 25% hydrogen bromide / acetic acid in 5 ml of dichloroethane solution
Was added and stirred at room temperature for 15 hours. After the reaction, the solution was distilled off, and the obtained residue was purified by column chromatography (silica; 50 g, developing solvent; ethyl acetate: n-hexane = 1: 4), and crystallized from ether and n-hexane. And collected by filtration to obtain 55 mg of 4-desoxy-4'-demethyl-4- (1-propyl) -4-epipodophyllotoxin (compound 3).
(71.7% yield).

融点 189〜191℃ ▲[α]20 D▼=−78.03(C=0.346,CHCl31 H−NMR δppm(CDCl3) 6.69(1H,s,5位H),6.45(1H,s,8位H),6.29(2
H,s,2′,6′位H), 5.41(1H,s,−CH),4.57(1H,m,1位H), 3.77(6H,s,OCH3×2),2.80−3.20(3H,m,2位,3位,4位
H),1.20−1.80(4H,m,−CH2CH2CH3),0.98(3H,t,J=
5.9Hz,−CH3) 実施例4 4−デソキシ−4−(2,3−ジヒドロキシ−1−プロピ
ル)−4−エピポドフィロトキシン(化合物4)の合成 実施例1で得た4−デソキシ−4−アリル−4−エピ
ポドフィロトキシン100mg(0.23mmol)のピリジン溶液2
mlに四酸化オスミウム58mg(0.23mmol)を加え、室温で
1時間攪拌した。反応跡、亜硫酸水素ナトリウム0.1gの
含水ピリジン溶液を加え、30分撹拌した。反応混合物を
酢酸エチルにて抽出し、希塩酸、水で洗浄した後、乾燥
した。有機層を濃縮後、得られた残査をカラムクロマト
グラフィー(シリカ;50g、展開溶媒;クロロホルム:メ
タノール=20:1)で精製した。濃縮して得られた残査を
エーテル、n−ヘキサンにて結晶化させ、濾集し、4−
デソキシ−4−(2,3−ジヒドロキシ−1−プロピル)
−4−エピポドフィロトキシン(化合物4)を97mg(収
率89.3%)得た。
Melting point 189-191 ° C ▲ [α] 20 D ▼ = −78.03 (C = 0.346, CHCl 3 ) 1 H-NMR δppm (CDCl 3 ) 6.69 (1H, s, 5-position H), 6.45 (1H, s, 8) H), 6.29 (2
H, s, 2 ', 6'H), 5.41 (1H, s, -CH), 4.57 (1H, m, 1st H), 3.77 (6H, s, OCH 3 × 2), 2.80-3.20 (3H, m, 2nd, 3rd, 4th H), 1.20-1.80 (4H, m, -CH 2 CH 2 CH 3 ), 0.98 ( 3H, t, J =
5.9 Hz, -CH 3) obtained in Example 4 4- desoxy-4- (2,3-dihydroxy-1-propyl) -4-epi-podophyllotoxin Synthesis Example 1 of toxin (Compound 4) 4- desoxy Solution of 100 mg (0.23 mmol) of -4-allyl-4-epipodophyllotoxin in pyridine 2
58 mg (0.23 mmol) of osmium tetroxide was added to the ml, and the mixture was stirred at room temperature for 1 hour. A reaction trace, a hydrous pyridine solution of 0.1 g of sodium bisulfite was added, and the mixture was stirred for 30 minutes. The reaction mixture was extracted with ethyl acetate, washed with diluted hydrochloric acid and water, and dried. After concentrating the organic layer, the obtained residue was purified by column chromatography (silica; 50 g, developing solvent: chloroform: methanol = 20: 1). The residue obtained by concentration was crystallized from ether and n-hexane, and collected by filtration.
Desoxy-4- (2,3-dihydroxy-1-propyl)
97 mg (yield 89.3%) of -4- epipodophyllotoxin (compound 4) was obtained.

融点144〜145℃ ▲[α]20 D▼=−73.42(C=0.520,CHCl31 H−NMR δppm(CDCl3) 6.87,6.80(1H,s,5位H),6.44,6.42(1H,s,8位H),6.
28,6.26(1H,s,2′,6′位H), 4.53(1H,m,1位H), 3.79(3H,s,OCH3),3.73(6H,s,OCH3×2),3.58−3.68
(1H,m,−CH(OH)CH2OH),3.24−3.58(2H,m,−CH(O
H)CH2OH),2.60−3.24(5H,m,2位,3位,4位H,−CH(O
H)CH2OH),1.28−2.00(2H,m,−CH2CH(OH)CH2OH) 実施例5 4−デソキシ−4−(2,3−ジアセトキシ−1−プロピ
ル)−4−エピポドフィロトキシン(化合物5)の合成 実施例4で得た4−デソキシ−4−(2,3−ジヒドロ
キシ−1−プロピル)−4−エピポドフィロトキシン90
0mg(1.90mmol)のテトラヒドロフラン溶液5mlに無水酢
酸428mg(4.19mmol)及びジメチルアミノピリジン10mg
を加え、室温で2日間撹拌した。反応後、希塩酸を加
え、酢酸エチルで抽出した。有機層を食塩水、水で洗浄
した後、乾燥した。溶媒を留去して得られた残査をカラ
ムクロマトグラフィー(シリカ;50g、展開溶媒;クロロ
ホルム:メタノール=50:1)で精製した。濃縮して得ら
れた残査をエーテル、n−ヘキサンにて結晶化させ、濾
集し、4−デソキシ−4−(2,3−ジアセトキシ−1−
プロピル)−4−エピポドフィロトキシン(化合物5)
を927mg(収率87.7%)得た。
144-145 ° C ▲ [α] 20 D ▼ = -73.42 (C = 0.520, CHCl 3 ) 1 H-NMR δ ppm (CDCl 3 ) 6.87,6.80 (1H, s, 5-position H), 6.44,6.42 (1H , s, 8th H), 6.
28,6.26 (1H, s, 2 ', 6'-position H), 4.53 (1H, m, 1st H), 3.79 (3H, s, OCH 3 ), 3.73 (6H, s, OCH 3 × 2), 3.58-3.68
(1H, m, -CH (OH ) CH 2 OH), 3.24-3.58 (2H, m, -CH (O
H) CH 2 OH), 2.60-3.24 (5H, m, 2 , 3, 4 H, -CH (O
H) CH 2 OH), 1.28-2.00 (2H, m, -CH 2 CH (OH) CH 2 OH) Example 5 4- desoxy-4- (2,3-diacetoxy-1-propyl) -4-epi Synthesis of podophyllotoxin (compound 5) 4-desoxy-4- (2,3-dihydroxy-1-propyl) -4-epipodophyllotoxin 90 obtained in Example 4
428 mg (4.19 mmol) of acetic anhydride and 10 mg of dimethylaminopyridine were added to 5 ml of a 0 mg (1.90 mmol) tetrahydrofuran solution.
Was added and stirred at room temperature for 2 days. After the reaction, diluted hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The organic layer was washed with brine and water, and then dried. The residue obtained by distilling off the solvent was purified by column chromatography (silica; 50 g, developing solvent: chloroform: methanol = 50: 1). The residue obtained by concentration was crystallized from ether and n-hexane, collected by filtration, and treated with 4-desoxy-4- (2,3-diacetoxy-1-).
Propyl) -4-epipodophyllotoxin (compound 5)
927 mg (87.7% yield).

融点 92〜93℃ ▲[α]20 D▼=−52.52(C=0.495,CHCl31 H−NMR δppm(CDCl3) 6.65(1H,s,5位H),6.45(1H,s,8位H),6.26(2H,s,
2′,6′位H), 4.80−5.40(1H,b,−CH(OAc)CH2OAc),4.54(1H,m,1
位H), 3.79(3H,s,OCH3),3.74(6H,s,OCH3×2),2.80−3.20
(3H,m,2位,3位,4位H),2.20,2.12,2.11,2.08(6H,s,
−OCOCH3),1.68−2.00(2H,m,−CH2CH(OAc)−) 実施例6 4−デソキシ−4′−デメチル−4−アリル−4−エピ
ポドフィロトキシン(化合物6)の合成 4′−デメチル−4−エピポドフィロトキシン100mg
(0.25mmol)のジクロロメタン2.5ml溶液にトリメチル
アリルシラン60mg(0.53mmol)を加え、−20〜0℃に冷
却した。この溶液に三フッ化ホウ素エチルエーテル74μ
を加え、3時間撹拌した。反応後、ピリジン74μを
加え、酢酸エチルで抽出した。有機層を乾燥後留去し、
カラムクロマトグラフィー(シリカ;50g、展開溶媒;酢
酸エチル:n−ヘキサン=3:2)で精製後、ジエチルエー
テルにて結晶化させ、濾集し、4−デソキシ−4′−デ
メチル−4−アリル−4−エピポドフィロトキシン(化
合物6)を52mg(収率49.1%)得た。
Melting point 92-93 ° C ▲ [α] 20 D ▼ = -52.52 (C = 0.495, CHCl 3 ) 1 H-NMR δ ppm (CDCl 3 ) 6.65 (1H, s, 5-position H), 6.45 (1H, s, 8) H), 6.26 (2H, s,
2 ', 6'-position H), 4.80-5.40 (1H, b, -CH ( OAc) CH 2 OAc), 4.54 (1H, m, 1
H), 3.79 (3H, s, OCH 3 ), 3.74 (6H, s, OCH 3 × 2), 2.80-3.20
(3H, m, 2nd, 3rd, 4th H), 2.20,2.12,2.11,2.08 (6H, s,
-OCOCH 3), 1.68-2.00 (2H, m, -CH 2 CH (OAc) -) Example 6 4- desoxy-4'-demethyl-4-allyl-4-epipodophyllotoxin (Compound 6) Synthesis 4'-demethyl-4-epipodophyllotoxin 100mg
To a solution of (0.25 mmol) in 2.5 ml of dichloromethane was added 60 mg (0.53 mmol) of trimethylallylsilane, and the mixture was cooled to -20 to 0 ° C. To this solution, add boron trifluoride ethyl ether 74μ.
Was added and stirred for 3 hours. After the reaction, 74 μm of pyridine was added, and the mixture was extracted with ethyl acetate. The organic layer is evaporated after drying.
After purification by column chromatography (silica; 50 g, developing solvent; ethyl acetate: n-hexane = 3: 2), the product was crystallized from diethyl ether, collected by filtration, and 4-desoxy-4'-demethyl-4-allyl. 52 mg (yield 49.1%) of -4- epipodophyllotoxin (compound 6) was obtained.

融点 181〜182℃(分解) ▲[α]20 D▼=−90.94(C=0.552,CHCl31 H−NMR δppm(CDCl3) 6.72(1H,s,5位H),6.47(1H,s,8位H),6.29(2H,s,
2′,6′位H), 5.60−5.87(1H,m,−CH2CH=CH2),5.41(1H,s,4′位O
H),5.03−5.20(2H,m,−CH=CH2),4.55(1H,d,J=4.8
Hz,1位H),4.29, 2.87−3.44(3H,m,2位,3位,4位H),2.34−2.77(2H,m,
−CH2CH=CH2) 実施例7 4−デソキシ−4′−デメチル−4−(2,3−ジアセト
キシ−1−プロピル)−4−エピポドフィロトキシン
(化合物7)の合成 実施例5で得た4−デソキシ−4−(2,3−ジアセト
キシ−n−プロピル)−4−エピポドフィロトキシン50
0mg(0.90mmol)を、1,2−ジクロルエタン(12ml)とジ
エチルエーテル(1ml)の混合液に溶解し、25%臭化水
素/酢酸1mlを加え、室温で20時間撹拌した。反応後、
1%炭酸水素ナトリウム水溶液と酢酸エチルとの混合物
にて抽出後、水洗し乾燥した。溶媒を留去し、得られた
残査をカラムクロマトグラフィー(シリカ;50g、展開溶
媒;クロロホルム:メタノール=30:1)で精製した。濃
縮して得られた残差をエーテルにて結晶化させ、濾集
し、4−デソキシ−4−デメチル−4−(2,3−ジアセ
トキシ−1−プロピル)−4−エピポドフィロトキシン
(化合物7)を150mg(収率30.7%)得た。
Melting point 181-182 ° C (decomposition) ▲ [α] 20 D ▼ = -90.94 (C = 0.552, CHCl 3 ) 1 H-NMR δ ppm (CDCl 3 ) 6.72 (1H, s, 5-position H), 6.47 (1H, s, 8th H), 6.29 (2H, s,
2 ', 6'-position H), 5.60-5.87 (1H, m, -CH 2 CH = CH 2), 5.41 (1H, s, 4 ' position O
H), 5.03-5.20 (2H, m , -CH = CH 2), 4.55 (1H, d, J = 4.8
Hz, 1st H), 4.29, 2.87−3.44 (3H, m, 2nd, 3rd, 4th H), 2.34−2.77 (2H, m,
Synthesis Example of -CH 2 CH = CH 2) Example 7 4- desoxy-4'-demethyl-4- (2,3-diacetoxy-1-propyl) -4-epipodophyllotoxin (Compound 7) 5 4-Desoxy-4- (2,3-diacetoxy-n-propyl) -4-epipodophyllotoxin 50 obtained in
0 mg (0.90 mmol) was dissolved in a mixture of 1,2-dichloroethane (12 ml) and diethyl ether (1 ml), 1 ml of 25% hydrogen bromide / acetic acid was added, and the mixture was stirred at room temperature for 20 hours. After the reaction,
After extraction with a mixture of a 1% aqueous sodium hydrogen carbonate solution and ethyl acetate, the extract was washed with water and dried. The solvent was distilled off, and the obtained residue was purified by column chromatography (silica; 50 g, developing solvent: chloroform: methanol = 30: 1). The residue obtained by concentration was crystallized from ether, collected by filtration, and 4-desoxy-4-demethyl-4- (2,3-diacetoxy-1-propyl) -4-epipodophyllotoxin ( 150 mg (yield 30.7%) of compound 7) was obtained.

融点 169〜170℃ ▲[α]20 D▼=−106.25(C=0.448,CHCl31 H−NMR δppm(CDCl3) 6.65(1H,s,5位H),6.45(1H,s,8位H),6.28(2H,s,
2′,6′位H), 5.44(1H,s,OH),4.72−5.40(1H,b,−CH(OAc)CH2OA
c),4.53(1H,m,1位H), 3.77(6H,s,OCH3×2),2.60−3.20(3H,m,2位,3位,4位
H),2.20,2.12,2.11,2.08(6H,s,−OCOCH3),1.48−2.
00(2H,m,−CH2CH(OAc)−) 実施例8 4−デソキシ−4′−デメチル−4−(2,3−ジヒドロ
キシ−1−プロピル)−4−エピポドフィロトキシン
(化合物8)の合成 実施例7で得た4−デソキシ−4′−デメチル−4−
(2,3−ジアセトキシ−1−プロピル)−4−エピポド
フィロトキシン100mg(0.18mmol)のメタノール溶液5ml
に酢酸亜鉛30mg(0.16mmol)を加え、6時間還流撹拌し
た。反応後、カラムクロマトグラフィー(シリカ;50g、
展開溶媒;クロロホルム:メタノール=15:1)で精製し
た。濃縮して得られた残査をエーテルにて結晶化させ、
濾集し、4−デソキシ−4′−デメチル−4−(2,3−
ジヒドロキシ−1−プロピル)−4−エピポドフィロト
キシン(化合物8)を60mg(収率72.8%)得た。
Melting point 169-170 ° C ▲ [α] 20 D ▼ = -106.25 (C = 0.448, CHCl 3 ) 1 H-NMR δ ppm (CDCl 3 ) 6.65 (1H, s, 5-position H), 6.45 (1H, s, 8) H), 6.28 (2H, s,
2 ', 6'-position H), 5.44 (1H, s, OH) , 4.72-5.40 (1H, b, -CH (OAc) CH 2 OA
c), 4.53 (1H, m, 1st H), 3.77 (6H, s, OCH 3 × 2), 2.60−3.20 (3H, m, 2nd, 3rd, 4th H), 2.20,2.12,2.11,2.08 (6H, s, −OCOCH 3 ), 1.48− 2.
00 (2H, m, -CH 2 CH (OAc) -) Example 8 4-desoxy-4'-demethyl-4- (2,3-dihydroxy-1-propyl) -4-epipodophyllotoxin (Compound Synthesis of 8) 4-Desoxy-4'-demethyl-4- obtained in Example 7
5 ml of a methanol solution of 100 mg (0.18 mmol) of (2,3-diacetoxy-1-propyl) -4-epipodophyllotoxin
To the mixture was added 30 mg (0.16 mmol) of zinc acetate, and the mixture was stirred under reflux for 6 hours. After the reaction, column chromatography (silica; 50 g,
Purified with a developing solvent; chloroform: methanol = 15: 1). The residue obtained by concentration is crystallized from ether,
It was collected by filtration and 4-desoxy-4'-demethyl-4- (2,3-
60 mg (yield 72.8%) of dihydroxy-1-propyl) -4-epipodophyllotoxin (compound 8) was obtained.

融点 131〜133℃ ▲[α]20 D▼=−74.53(C=0.530,CHCl31 H−NMR δppm(CDCl3) 6.87,6.80(1H,s,5位H),6.43,6.42(1H,s,8位H),6.
27,6.26(1H,s,2′,6′位H), 5.41(1H,s,4′位OH),4.53(1H,m,1位H), 3.73(6H,s,OCH3×2),3.58−3.68(1H,m,−CH(OH)C
H2OH),3.24−3.58(2H,m,−CH(OH)CH2OH),2.60−3.
24(5H,m,2位,3位,4位H,−CH(OH)CH2OH),1.28−2.00
(2H,m,−CH2CH(OH)CH2OH) 薬理試験 P388細胞及びS180細胞をそれぞれ2×103cells/wel
l、5×103cells/wellで24穴プレートに播種した後、薬
剤を接触させた。薬剤はジメチルスルホキドに溶解させ
た後、ジメチルスルホキシドの最終濃度が0.1%以下に
なるように希釈した。4日間の連続接触の後、生細胞の
数を血球計算盤により計測した。増殖阻害率を下記式に
より計算し、50%増殖阻害を示す薬剤濃度をED50値とし
て表わした。
131-133 ° C. ▲ [α] 20 D ▼ = −74.53 (C = 0.530, CHCl 3 ) 1 H-NMR δ ppm (CDCl 3 ) 6.87,6.80 (1H, s, 5-position H), 6.43,6.42 (1H , s, 8th H), 6.
27,6.26 (1H, s, 2 ', 6'-position H), 5.41 (1H, s, 4'-OH), 4.53 (1H, m, 1H), 3.73 (6H, s, OCH 3 × 2), 3.58-3.68 (1H, m, -CH (OH) C
H 2 OH), 3.24-3.58 (2H , m, -CH (OH) CH 2 OH), 2.60-3.
24 (5H, m, 2, 3, 4 H, -CH (OH) CH 2 OH), 1.28-2.00
(2H, m, -CH 2 CH (OH) CH 2 OH) Pharmacological test P388 cells and S180 cells were each 2 × 10 3 cells / weld
1, 5 × 10 3 cells / well were seeded on a 24-well plate, and then contacted with the drug. The drug was dissolved in dimethyl sulfoxide and then diluted so that the final concentration of dimethyl sulfoxide was 0.1% or less. After 4 days of continuous contact, the number of viable cells was counted with a hemocytometer. The growth inhibition rate was calculated by the following equation, representing the drug concentration showing 50% growth inhibition as ED 50 values.

結果を第1表に示す。 The results are shown in Table 1.

フロントページの続き (72)発明者 武田 節夫 徳島県名西郡石井町石井字石井1624―6 番地 (72)発明者 ヴィエジバ コンスタンティ 徳島県板野郡北島町北村字新川屋41―2 (72)発明者 小武内 尚 徳島県徳島市川内町加賀須野463―10Continued on the front page (72) Inventor Setsuo Takeda 1624-6 Ishii, Ishii-cho, Ishii-cho, Meishi, Tokushima (72) Inventor Viezyba Constanty 41-2 Shinkawaya, Kitamura, Kitajima-cho, Itano-gun, Tokushima (72) Inventor Small Takashi Takeuchi 463-10 Kagasuno, Kawauchi Town, Tokushima City, Tokushima Prefecture

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】一般式 [式中R1は水素原子又はメチル基を、Rは低級アルケニ
ル基又は置換基として水酸基若しくはアセトキシ基を有
してもよい低級アルキル基を示す。]で表わされる4−
デソキシ−4−エピポドフィロトキシン誘導体。
(1) General formula [In the formula, R 1 represents a hydrogen atom or a methyl group, and R represents a lower alkenyl group or a lower alkyl group which may have a hydroxyl group or an acetoxy group as a substituent. 4- represented by
Desoxy-4-epipodophyllotoxin derivatives.
JP26785589A 1989-10-12 1989-10-12 4-desoxy-4-epipodophyllotoxin derivatives Expired - Fee Related JP2587705B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP26785589A JP2587705B2 (en) 1989-10-12 1989-10-12 4-desoxy-4-epipodophyllotoxin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26785589A JP2587705B2 (en) 1989-10-12 1989-10-12 4-desoxy-4-epipodophyllotoxin derivatives

Publications (2)

Publication Number Publication Date
JPH03127792A JPH03127792A (en) 1991-05-30
JP2587705B2 true JP2587705B2 (en) 1997-03-05

Family

ID=17450572

Family Applications (1)

Application Number Title Priority Date Filing Date
JP26785589A Expired - Fee Related JP2587705B2 (en) 1989-10-12 1989-10-12 4-desoxy-4-epipodophyllotoxin derivatives

Country Status (1)

Country Link
JP (1) JP2587705B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW221441B (en) * 1991-01-25 1994-03-01 Taiho Pharmaceutical Co Ltd

Also Published As

Publication number Publication date
JPH03127792A (en) 1991-05-30

Similar Documents

Publication Publication Date Title
JPS6365657B2 (en)
WO2013174848A2 (en) Improved process for the preparation of treprostinil and derivatives thereof
FR2527615A1 (en) PROCESS FOR PREPARING 26,26,26,27,27,27-HEXAFLUORO-1A, 25-DIHYDROXYCHOLESTEROL
JPS6345293A (en) Sialosylceramide compound and production thereof
JP2587705B2 (en) 4-desoxy-4-epipodophyllotoxin derivatives
JP2001247594A (en) Method of producing flavonoid compound
JPH09328498A (en) Production of 24,25-dihydroxycholesterol and its synthetic intermediate
JP3138834B2 (en) Method for producing fucopyranose analog and intermediate compound thereof
JPH058200B2 (en)
JP2641363B2 (en) Novel phenethyl alcohol and its production method
US5502221A (en) Process for producing cyclohexylbutyric acid derivative
JPH0463056B2 (en)
HU200344B (en) Process for producing stalosyl glyceride derivatives
JPH0222254A (en) 2,3-diaminopropionic acid derivative
JP2002255888A (en) Method for 4-demethoxydaunomycin production
JP2754095B2 (en) Novel bicyclo [8.3.0] trideca-9,13-diene-2,7-diyne derivative
JPH03123780A (en) 2h-benzo(b)quinolidine derivative
JP3852618B2 (en) Method for oxidizing 6-hydroxyhexanoic acids
JP2711762B2 (en) Bicyclo [8.3.0] trideca-9,13-diene-2,7-diyne derivative
JP2791572B2 (en) Macrocyclic compound and method for producing the same
JPS6372696A (en) Production of 1,5-anhydro-d-fructose and hydrate thereof
JPS61180734A (en) Cyclopentane derivative
JPS632251B2 (en)
JPH05239062A (en) Synthesis of intermediate for synthesizing mycalamide
JPS6127948A (en) Preparation of clavulone derivative

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees